Cerba Lab raises €80m for acquisition of JS Bio

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Corporate Bonds
High yield

Cerba Lab raises €80m for acquisition of JS Bio

Jon Hay
April 24, 2014 10:00 pm

Cerba European Lab, the French clinical pathology testing business, issued an €80m high yield bond tap on Thursday to finance its acquisition of JS Bio.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

High yieldNews contentLevFin High Yield BondsLevFinPrivate EquityCorporate Bonds
JH
Jon Hay
Gift this article